A nationwide case-referent study on elevated risks of adenocarcinoma lung cancer by long-term PM 2.5 exposure in Taiwan since 1997

• Published in: Environmental research p. 118889
• Main Authors: Lin, Wei-Chi, Shie, Ruei-Hao, Yuan, Tzu-Hsuen, Tseng, Chien-Hua, Chiang, Chun-Ju, Lee, Wen-Chung, Chan, Chang-Chuan
• Format: Journal Article
• Language: English
• Published: Netherlands 01.07.2024
• Subjects: EGFR mutation; particulate matter pollution; adenocarcinoma lung cancer; cancer stage; smoking
• ISSN: 1096-0953
• DOI: 10.1016/j.envres.2024.118889

The effects of long-term PM exposures since 1968 on adenocarcinoma lung cancer (AdLC) were not studied before. This case-referent study used nationwide cancer registry data since 1997 and air pollution data since 1968 in Taiwan to estimate risks of 30-year PM exposures on AdLC. Cases were all AdLC, while references were all non-AdLC. Individuals' 30-year PM exposures were estimated by PM levels at their residence for 30 years prior their diagnosis dates. We applied multiple logistic regression analyses to estimate PM exposures on incidence rate ratios (IRRs) between cases and references, adjusting for sex, age, smoking, cancer stage, and EGFR mutation. Elevation in annual ambient PM concentrations since 1968 were associated with increase in annual age-adjusted AdLC incidence since 1997. AdLC incidences were higher among females, nonsmokers, the elderly aged above 65, cases of stages IIIB to IV, and EGFR mutation. Study subjects' PM exposures averaged at 33.7±7.4 μg/m with 162±130 high PM pollution days over 30 years. Multiple logistic models showed an increase in 10 μg/m of PM exposures were significantly associated with 1.044 of IRR between all AdLC and all non-AdLC cases during 2011-2020. Our models also showed that females and nonsmokers and adults less than 65 years had higher IRRs than their respective counterparts. Restricted analyses showed similar effects of PM exposures on IRRs between stage 0-IIIA and IIIB-IV cases and between EGFR+ and EGFR- cases. Long-term exposures to PM over 30 years were associated with elevated risks of AdLC against non-AdLC, regardless of gender, age, smoking status, cancer stage, or EGFR mutation.